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Background: The genetic variability of Leishmania (Viannia) braziliensis was assessed at intra and interpatient levels
of individuals with different clinical manifestations of American tegumentary leishmaniasis (ATL).
Methods: Fifty-two samples, of which 13 originated from cutaneous lesions and 39 from mucosal lesions, provided
by 35 patients, were examined by low-stringency single-specific-primer PCR (LSSP-PCR) and phenetic analysis.
Genetic variability of L. (V.) braziliensis, in kinetoplast DNA (kDNA) signatures, was compared both from different
patients and from different lesions of the same patient. Phenetic analysis was performed to evaluate the degree of
heterogeneity of the kDNA minicircles. In order to evaluate inter and intrapatient L. (V.) braziliensis genetic
variability, the percentage of shared bands and analysis of the coefficients of similarity were analyzed.
Results: Different genetic profiles, representing kDNA signatures of the parasite, were obtained by LSSP-PCR
analysis of each sample. Phenetic analysis grouped genetic profiles of different levels of differentiation from more
similar to most divergent. The percentage of shared bands at the inter and intrapatient levels was 77% and 89%,
respectively. Comparison of the average inter and intrapatient coefficients of similarity and their standard deviations
were statistically significant (p < 0.001).
Conclusion: Genetic variability at the intrapatient level was less pronounced than that between different patients.
A conceptual model was proposed to better understand the complexity at both levels.
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Leishmaniasis is a disease ranging from potential self-
healing cutaneous lesions to mucosal disorders to more
severe visceral affliction possibly resulting in death, all de-
pending upon the species of Leishmania, the protozooan
etiological agent.
American tegumentary leishmaniasis (ATL) caused by
Leishmania (Viannia) braziliensis is characterized by
chronicity, latency and metastatic tendencies. In some* Correspondence: rpacheco@ioc.fiocruz.br
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reproduction in any medium, provided the orcases, after the appearance of an initial cutaneous lesion,
multiple cutaneous lesions (disseminated leishmaniasis,
DL) and/or mucosal lesions (mucosal leishmaniasis, ML)
can arise as a consequence of the dissemination of the
parasite through the blood and lymphatic systems [1-3].
Cutaneous lesions can remain active for many years and
can coexist with mucosal lesions, as exhibited in the
mucocutaneous leishmaniasis (MCL) form [4]. Less than
5% of cutaneous leishmaniasis cases develop destructive
lesions in the upper respiratory tract, primarily in the
nasal mucosa [5], and more than 25% of the DL cases
present damaged mucosa simultaneously with cutaneous
manifestations [6]. However, approximately 16% of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tial cutaneous lesion [7].
Factors such as the immunological response of the pa-
tient and the genetic constitution of the parasite could
influence the clinical manifestations and prognosis of
this disease. It is also quite possible that these factors
play a role in parasite persistence. Parasite persistence
and reactivation have been reported to be contributing
factors towards recurring episodes of ATL [8-10]. How-
ever, the mechanism of the dissemination and emergence
of L. (V.) braziliensis to new cutaneous and mucosal tissue,
the pathogenic process as well as the natural history of the
recurrent leishmaniasis is not yet fully understood.
Human infection by L. (V.) braziliensis produces a
broad spectrum of clinical manifestations that can be
attributed to intraspecific variability of the parasite. The
contribution of the parasite to the diversity of ATL pa-
tient clinical conditions has been examined in several
studies aiming to investigate whether certain species
and/or clonal populations of Leishmania are correlated
with any clinical manifestations of the disease. Intraspe-
cific heterogeneity among members of the subgenera
Viannia and Leishmania was detected by genetic and
molecular studies, which have afforded a better under-
standing of their epidemiology in diverse endemic areas
[11-14].
Different polymorphic molecular markers based on
the polymerase chain reaction (PCR) have been used in
several studies of the L. (V.) braziliensis genetic variabil-
ity and molecular epidemiology. The importance of this
particular species was demonstrated by the existence of
various intraspecific genetic polymorphisms and the va-
riability of the clinical manifestations observed in ATL.
Previous studies have established a correlation between
genetic polymorphisms and the eco-epidemiological data
of isolates [15-17]. Such studies reinforce the clonal
population structure of Leishmania, as proposed by
Tibayrenc et al. [18]. Leishmania species naturally circu-
late as a group of heterogeneous subpopulations, and
demonstration of the polyclonality of the initial inocu-
lum of multiple strains has been reported [19]. These
mechanisms could influence the clinical prognosis of the
disease and the efficiency of therapeutic strategies.
Our group recently introduced the application of low-
stringency single-specific-primer PCR (LSSP-PCR) to-
wards the investigation of intraspecific polymorphisms
in the variable region of the kinetoplast DNA (kDNA)
minicircles of L. (V.) braziliensis in ATL patients [20,21].
The purpose of the present study is to further investigate
parasite subpopulations, with a particular focus on the
genetic variability of L. (V.) braziliensis at intra and
interpatient levels, using the same molecular marker as-
sociated with phenetic analyses. Towards this end, sam-
ples obtained from cutaneous and mucosal lesions ofpatients with different clinical manifestations of ATL
from Rio de Janeiro, Brazil were analyzed.Methods
Patients
This study included 35 patients from Rio de Janeiro, Brazil,
presenting ATL and mucosal involvement, each attended
at the Laboratório de Vigilância em Leishmanioses/Lab.
VigiLeish, Instituto de Pesquisa Clínica Evandro Chagas –
IPEC/Fiocruz, Rio de Janeiro, from January 2005 to
December 2009. Patients were grouped according to their
clinical manifestations in the following three categories: i)
mucocutaneous leishmaniasis (MCL) for patients that
presented cutaneous and mucosal lesions in contiguous
and concomitant forms, ii) mucosal leishmaniasis (ML) for
patients that presented only mucosal lesions (nasal and/or
oral) and iii) disseminated leishmaniasis (DL) for patients
presenting more than 10 cutaneous lesions and mucosal
involvement. All patients were subjected to dermatological
and otolaryngological examination, including direct inspec-
tion of the upper respiratory tract using rigid optic Karl
Storz 70° and 30°, to assess, respectively, the presence or
absence of larynx and pharyngeal or nasal lesions. This
study was approved by the Ethical Committee of Research
at IPEC/FIOCRUZ (process 0016.0.009-02), and all of the
patients signed consent forms.Molecular diagnosis by PCR and low-stringency
single-specific-primer PCR (LSSP-PCR) reactions
Patient biopsy samples from cutaneous and/or mucosal
lesions were processed for molecular analysis. Extraction
of DNA and molecular diagnostic PCR-based assays
were performed as previously described [21,22]. The
750 bp fragments generated by specific PCR were puri-
fied with a Wizard PCR Prep System (Promega, Madi-
son, WI) according to the manufacturer’s instructions.
The purified products were then submitted to a second
round of amplification (LSSP-PCR) with only one spe-
cific primer under low stringency conditions. Reac-
tion conditions and visualization of the products were
performed as described by Oliveira et al. [21].Phenetic analysis
Bands varying in size from 350–750 bp were selected for
phenetic analysis. Analysis of the profiles generated by
LSSP-PCR was performed by calculating the levels of
similarity using the Simple Matching Coefficient (Sm).
The matrix of similarity was transformed into a dendro-
gram through the Unweighted Pair Group Method
Arithmetical Average (UPGMA) algorithm with the
NTSYS version 2.1 program (Exeter Software).
Table 1 Clinical and epidemiological characteristics of the 35 patients analysed in this study
Patient code Age (years) Sex Clinical form
Location of lesion/Code
Cutaneous Mucosal
1 52 M MCL Arm/1MCL-C Oral / 1MCL-O
2 48 M MCL Nostril/2MCL-C Oral/2MCL-O
3 25 M MCL Arm/3MCL-C Nasal/3MCL-N
4 54 M MCL ND Oral/4MCL-O
5 47 M MCL Arm/5MCL-C Nasal/5MCL-N
Oral/5MCL-O
6 16 M MCL ND Nasal/6MCL-N
7 50 M MCL Face/7MCL-C Nasal/7MCL-N
8 29 M MCL Trunk/8LMC-C Nasal/8MCL-N
9 55 M MCL ND Oral/9MCL-O
10 42 M MCL ND Nasal/10MCL-N
11 52 F MCL Arm/11MCL-C Nasal/11MCL-N
12 25 M MCL Trunk/12MCL-C Oral/12MCL-O
13 52 F MCL ND Oral/13MCL-O
14 54 M MCL Upper lip/14MCL-C Nasal/14MCL-N
15 69 M MCL ND Nasal/15MCL-N
16 65 M MCL ND Oral/16MCL-O
17 63 F ML A Nasal/17ML-N
18 53 M ML A Nasal/18ML-N
19 66 F ML A Nasal/19ML-N
20 71 M ML A Nasal/20ML-N
21 12 M ML A Nasal/21ML-N
22* 49 F ML A Nasal/22ML-N
23* 69 M ML A Nasal/23ML-N
24* 60 M ML A Nasal/24ML-N
25* 77 M ML A Nasal/25ML-N
26* 72 M ML A Nasal/26ML-N
27* 71 F ML A Nasal/27ML-N
28* 39 M ML A Nasal/28ML-N
29* 63 M ML A Nasal/29ML-N
30* 44 F ML A Nasal/30ML-N
31* 31 F ML A Nasal/31ML-N1
Nasal/31ML-N2
32* 29 F ML A Nasal/32ML-N1
Nasal/32ML-N2
33* 72 F ML A Oral/33LM-O
34 49 M DL Arm/ 34DL-C1 Nasal/34DL-N
Trunk/34DL-C2
Leg/34DL-C3
35 41 M DL Nose/35DL-C Nasal/35DL-N
Oral/35DL-O
*, Patients reporting the absence of an initial cutaneous lesion or scar suggestive of leishmaniasis; M male, F female, MCL, mucocutaneous leishmaniasis, ML
mucosal leishmaniasis, DL disseminated leishmaniasis, ND not done, A absence of cutaneous lesion at the time of clinical evaluation.
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Interpatient genetic variability was evaluated by: i) ob-
taining the coefficients of similarity between the patient
sample and all of the other samples (from all of the pa-
tients), ii) calculating the arithmetic averages and their
respective standard deviations of those interpatient coef-
ficients of similarity and iii) calculating the average of
those mean values, with the aim of estimating the aver-
age interpatient similarity (i.e. the variability existing
among parasites recovered from lesions of different pa-
tients). Intrapatient genetic variability was estimated by
calculating the average of the mean coefficient of simi-
larity of each patient, taking into account the cutaneous
and mucosal lesions present in the same patient. The av-
erages and standard deviations (SD) of the inter and
intrapatient coefficients of similarity were compared ap-
plying the student’s t-test.A
B





Figure 1 kDNA signatures of L. (V.) braziliensis obtained by LSSP-PCR
electrophoresis showing representative genetic profiles derived from ampli
patients. Lanes: M – Molecular marker (100 bp ladder); lanes 1–5: 22ML-N, 2
11MCL-C, 3MCL-N, 3MCL-C, 5MCL-N, 5MCL-O and 5MCL-C. B: UPGMA dend
on the genetic profiles obtained by LSSP-PCR. Lb, L. (V.) braziliensis referenc
ML: mucosal leishmaniasis; DL: disseminated leishmaniasis; N: nasal; O: oral;
at different moments; N1 and N2: different samples of mucosal nasal lesionComparison of inter- and intra-patient similarities
was also performed by analyzing the percentages of
shared characters (bands), defined by genetic profiles
generated by LSSP-PCR. The sharing frequency of each
character between interpatient samples was calculated
after first calculating the average of each sharing fre-
quency. The same analysis was performed to compare
different lesions from the same patient.
Results
Clinical-epidemiological characteristics of the patients
The clinical forms of ATL exhibited by the patients
were: 16 with MCL, 17 with ML and 2 with DL. Of these
patients, 25 (71.4%) were male and 10 (28.6%) were fe-
male. Patient age varied from 12 to 77 years. The pres-
ence of lesions in the nasal mucosa was observed in 77%
of the patients. The two patients with DL (patients 34and phenetic analysis. A: 1.8% High Resolution agarose gel
fication of the 750 bp fragment from mucosal lesions of different
6ML-N, 29ML-N, 4MCL-O and 16MCL-O; lanes 6–12: 11MCL-N,
rogram showing the “Simple Matching” coefficients of similarity based
e strain (MHOM/BR/1975/M2903). MCL: mucocutaneous leishmaniasis;
C: cutaneous; C1-C3: different samples of cutaneous lesions collected
s collected at different moments.
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lesions. Only one patient with MCL (patient 5) displayed
concomitant nasal and oral mucosal lesions. Of the 17
patients with ML, 12 reported the absence of an initial
cutaneous lesion or scar suggestive of leishmaniasis.
Data are shown in Table 1.Molecular diagnostics and analysis of genetic variability
From the 35 patients, 52 tissue samples were analyzed,
of which 13 originated from cutaneous lesions and 39
from mucosal lesions. Samples from cutaneous and
mucosal lesions were only available from 9 of the 16 pa-
tients with MCL. From 2 of the patients with ML (pa-
tients 31 and 32), fragments of the mucosal nasal lesions
were collected at different times over a period of one
year. From patient 34 with DL, three samples of cutane-





























0.66 0.72 0.72 1.00
12MCL-
0
0.72 0.72 0.72 0.94 1.00
34DL-N 0.69 0.58 0.58 0.69 0.69 1.00
34DL-
C1
0.55 0.61 0.66 0.66 0.66 0.75 1.00
34DL-
C2
0.69 0.58 0.63 0.75 0.75 0.77 0.75 1.00
34DL-
C3
0.72 0.72 0.72 0.66 0.66 0.69 0.77 0.75
31 M1-
N1
0.66 0.72 0.72 0.77 0.77 0.63 0.66 0.63
31ML-
N2
0.50 0.55 0.50 0.55 0.61 0.58 0.55 0.52
9MCL-
O
0.72 0.66 0.66 0.77 0.83 0.69 0.55 0.75
15MCL-
N
0.75 0.63 0.63 0.80 0.80 0.72 0.69 0.72
23ML-
N
0.63 0.63 0.63 0.75 0.69 0.66 0.58 0.66
20ML-
N
0.72 0.77 0.77 0.77 0.83 0.63 0.61 0.63
33ML-
O
0.66 0.61 061 0.77 0.77 0.69 0.67 0.69
MCL mucocustaneous leishmaniasis, DL disseminated leishmaniasis, ML mucosal leis
lesion fragments collected at 2 different times, C1-C3 cutaneous lesion fragments cat the same time as the sample of the mucosal lesion
and one that was collected 6 months after treatment.
Internal controls for PCR inhibition were performed
by amplifying a 110 bp fragment of the human β-globin
gene. The expected 110 bp fragment was obtained in
each sample tested (data not shown), confirming the ab-
sence of internal inhibitors. The 750 bp diagnostic band
was evident in all samples analyzed (data not shown).
Different genetic profiles, representing kDNA signatures
of the parasite, were obtained by LSSP-PCR analysis of
each sample. Figure 1-A shows selected representative
results. Phenetic analysis grouped the LSSP-PCR pro-
files according to their coefficients of similarity (Sm),
which diverged from 0.53 to 0.94 (Figure 1-B). The
dendrogram illustrates that in two patients with MCL
(patients 12 and 11) samples of cutaneous and mucosal
lesions were genetically similar to each other, sharing a




















0.61 0.72 0.66 1.00
0.75 0.86 0.58 0.75 1.00
0.58 0.80 0.52 0.69 0.83 1.00
0.61 0.83 0.55 0.83 0.69 0.69 1.00
0.66 0.72 0.66 0.72 0.80 0.75 0.72 1.00
hmaniasis, N nasal lesion, O oral lesion, C custaneous lesion, N1 and N2 nasal































Figure 2 Conceptual model proposed by Pacheco RS and
Oliveira FS aiming to explain the dynamics of the circulating
populations of L. (V.) braziliensis at both intra and interpatient
levels in a specific endemic area. At interpatient level,
heterogeneous subpopulations (A-E) circulate among man, vectors,
domestic and sylvatic animals and such individuals would be
exposed to distinct selective pressures, to the polyclonality of the
initial inoculum and also to multiple independent infections. At
intrapatient level, the individual may act as a biological filter and the
situation takes into account the participation of both parasite
virulence factors and the immunological system of the host.
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35), the nasal and oral mucosal lesions also presented
similar genetic profiles (Sm = 0.94), although somewhat
differing genetic profiles (Sm = 0.78 and Sm = 0.82, re-
spectively) were apparent in the respective cutaneous
lesions. Patients 31 and 27, with the ML clinical condi-
tion, also showed similar genetic profiles in the samples
of their mucosal nasal lesions. On the other hand, dis-
tinct genetic profiles were detected in samples from the
cutaneous and mucosal lesions of patients 14, 3, 8 and
in the nasal mucosal lesions of patients 31 and 32,
which were collected at different times over a period of
one year. Interestingly, very divergent profiles were ob-
served in the cutaneous and mucosal lesion samples of
patient 34 and also in the mucosal lesion samples of pa-
tients 31, 17 and 32.
In order to evaluate interpatient genetic variability, the
percentage of shared bands was analyzed. This approach
was validated by first demonstrating that, on average,
each character (band) was shared by 77% of the patients.
Analysis of interpatient coefficients of similarity revealed
a similar average of 0.69 (SD = 0.05). On the other hand,
the average characters shared at the intrapatient level
was 89%, and the average of the average coefficients ofsimilarity was 0.80 (SD = 0.12). Comparison of the aver-
age inter and intrapatient coefficients of similarity and
their standard deviations were statistically significant
(p < 0.001). Table 2 represents the inter and intrapatient
values of the coefficient of similarity for selected repre-
sentative samples.
The conceptual model
We have proposed a conceptual model (Figure 2) as a
way to explain the dynamics of the circulating popula-
tions of L. (V.) braziliensis at both intra and interpatient
levels in a specific endemic area.
Discussion
Our group has recently been applying different molecu-
lar tools towards the study of specific diagnostics and
the genotypic behaviour of L. (V.) braziliensis subpopula-
tions in patients with mucocutaneous leishmaniasis
[20,21]. These studies served as a basis for the present
investigation, which aimed to explore the relationship
between genetic diversity of L. (V.) braziliensis at inter
and intrapatient levels presenting distinct clinical mani-
festations of ATL. At the same time, this study also
aimed to evaluate such genetic diversity following two
hypothetical scenarios: (i) the individual, by him/herself,
acting as a biological filter whereby highly adapted popu-
lations are selected and (ii) eco-epidemiological interac-
tions occurring in the endemic area as reflecting on
the dynamics of the circulating populations of L. (V.)
braziliensis. According to our conceptual model, the
situation at intrapatient level takes into account the
participation of both parasite virulence factors and the
immunological system of the host and that the reactiva-
tion of the disease would reflect in the emergence of
different parasite subpopulations. However, at the in-
terpatient level circumstance is that heterogeneous sub-
populations circulate among man and vectors as well as
domestic and sylvatic animals in simple and complex
epidemiological interactions. In such specific cases indi-
viduals would be exposed to distinct selective pressures,
to the polyclonality of the initial inoculum and also to
multiple independent infections. If the biological entity
that evolves is the clonal lineage [18], one can imagine
different clones being reshuffled and propagated in the
natural circulating population, sharing different factors
of virulence or competing for selective advantages such as
distinct growth rates and differential tropisms [23,24].
Genetic variability of L. (V.) braziliensis, demonstrated
here by polymorphisms of kDNA signatures, was identi-
fied among the patients and among different lesions of
the same patient. Phenetic analysis was adopted to
evaluate the degree of heterogeneity of the kDNA
minicircles and group them into genetic profiles of dif-
ferent levels of differentiation, from more similar to
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relationship between parasite genotype and clinical man-
ifestations of ATL, considerably divergent genetic pro-
files have been detected in nasal mucosal lesions of
patients with ML. Schriefer et al. [25] noted that a
higher frequency of a determined genotype of L. (V.)
braziliensis in certain isolates of ML originated from the
same endemic area in the state of Bahia.
This idea of multiple independent infections may be
an explanation corroborated by data from patient 34,
with DL, whose results display significant genetic diver-
sity in the minicircles from distinct cutaneous and mu-
cosal lesions collected both at the same time and also at
different moments over a short period of time.
Despite the existence of heterogeneity, genotypic simi-
larities between the samples from cutaneous and muco-
sal lesions were evident on the intrapatient level. The
average of the coefficients of similarities (0.80) was also
of major significance, indicating that the samples are
genetically related. Therefore, the intrapatient genetic
variability, less than that between different patients
(77%), must be a result that is also in accordance with
the percentage of shared intrapatient characters (89%).
Elegant studies have demonstrated that the host im-
mune system plays an important role in the selection of
parasite populations [26-28]. Considering this, it is pos-
sible that man may act as a biological filter towards the
selection of parasite subpopulations most adapted to de-
velop in the host organism, and in this case, subpopula-
tions can be responsible for either cutaneous or mucosal
pathologies as mentioned in our conceptual model.
From the epidemiological point of view, the complex
cycle of transmissions in which the individuals are ex-
posed is a very important factor for the possibility of
reinfections through the accumulation of multiple inde-
pendent infections in patients residing in endemic areas
[8,29]. The complexity of transmission cycles, involving
sylvatic and domestic mammals together with the phle-
botamine vectors surely contributes to the large diversity
of the natural population of L. (V.) braziliensis [30,31].
An understanding of the genetic diversity of circulating
parasite populations in a specific endemic area, as well
as an investigation of the clonality of the initial lesions,
is fundamentally important and assists us in interpreting
the inter and intrapatient variability.
Conclusion
This study addresses the genetic variability of L. (V.)
braziliensis, demonstrated by polymorphisms of kDNA
signatures, not only among the patients but also among
different lesions of the same patient. Despite the exist-
ence of heterogeneity, genotypic similarities between the
samples from cutaneous and mucosal lesions were evi-
dent at the intrapatient level, the genetic variability beingless pronounced than the variability between different
patients. A conceptual model was proposed to better
understand the complexity at both levels.
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